首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷癌症個人化醫學分子呈像/呈影劑核子醫學

市場調查報告書

商品編碼

1670879

放射治療全球市場報告 2025

Radiotheranostics Global Market Report 2025

出版日期: 2025年02月28日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年放射治療市場規模將快速成長。到 2029 年，這一數字將成長至 169.4 億美元，年複合成長率(CAGR)為 13.9%。預測期內的成長可歸因於癌症標靶治療的進步、腫瘤學研究的擴展、慢性病的增加以及治療診斷應用的成長。預測期內的主要趨勢包括診斷治療放射性藥物的發展、腫瘤學以外應用的擴展、個人化放射性藥物、放射熱療中的奈米技術、監管變化和標準化。

預計未來癌症發生率的上升將推動放射治療市場的成長。癌症的特徵是體內某些細胞不受控制地發展，疾病擴散到身體的其他部位。放射熱療藥物廣泛應用於腫瘤學，透過配對診斷和治療放射性核種探針提供了個人化醫療的概念。這些探針可以根據患者的具體情況，選擇性、有針對性地檢測和治療特定細胞（通常是癌細胞），從而增強治療效果並改善臨床結果。例如，2024年1月，美國一家專注於癌症宣傳的非營利組織美國癌症協會報告稱，癌症患者數量從2023年的1,958,310人增加到2,011,140人，增加了2.19%。因此，癌症發生率的上升推動了放射治療市場的發展。

個人化醫療的日益普及預計將促進放射治療市場的成長。個人化醫療是一種創新的醫療保健方法，它透過放射熱療法實現，可根據每個患者的特徵制定治療方案。這種方法利用特定的放射性藥物，可以識別單一分子標靶，從而根據患者的特定特徵進行精確診斷和量身定做的治療性介入。根據精準醫學聯盟統計，2022年，食品藥物管理局藥品評估和研究中心（CDER）核准了37種新的生物製藥（NME），其中約34%被歸類為精準藥物。個人化醫療的日益普及是放射治療市場成長的關鍵因素。

世界無線電溫度計 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
最終用途產業分析
全球放射熱療市場：成長率分析
全球放射治療市場表現：規模與成長，2019 年至 2024 年
全球放射熱療市場預測：2024-2029 年及 2034 年規模與成長
全球放射熱療儀總目標市場 (TAM)

第6章市場細分

全球放射性同位素放射治療市場現況及預測，2019-2024 年、2024-2029 年、2034 年
Technetium-99
鎵-68
碘-131
碘-123
氟脫氧葡萄糖-18F
釔90
鎦(Lu) 177
銅（Cu） 67
銅（Cu） 64
其他放射性同位素
全球放射治療市場（依方法、績效與預測），2019-2024 年、2024-2029 年、2034 年
標靶治療
目標診斷
全球放射熱療市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
腫瘤學
非腫瘤學
全球放射熱療市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
醫院和診所
製藥和生物技術公司
其他最終用戶
全球放射熱療市場、Technetium-99 的細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
Technetium-99m
Technetium-99Technetium
全球放射熱成像市場，鎵-68 細分市場，按放射性同位素分類，實際和預測，2019-2024 年、2024-2029 年、2034 年
鎵-68酸鹽
鎵-68 PSMA
全球放射熱療市場、放射性同位素碘-131 細分市場、績效及預測，2019-2024 年、2024-2029 年、2034 年
碘-131用於治療甲狀腺癌
碘-131治療甲狀腺亢進
全球放射熱療市場、放射性同位素碘-123 細分市場、績效及預測，2019-2024 年、2024-2029 年、2034 年
碘-123 用於甲狀腺掃描
碘-123 用於心臟影像影像
全球放射熱療市場、放射性同位素氟脫氧葡萄糖-18F (FDG) 細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
FDG 在腫瘤成像的應用
FDG 用於腦部影像
全球放射熱成像市場、釔-90 放射性同位素細分市場、績效及預測，2019-2024 年、2024-2029 年、2034 年
釔-90微球用於治療肝癌
釔-90用於放射免疫治療
全球放射熱療市場，按放射性同位素鎦(Lu) 177 細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
鎦 - 177 PSMA 用於治療前列腺癌
鎦-177 DOTATATE 用於神經內分泌腫瘤
全球放射熱成像市場、放射性同位素銅 (Cu) 67 個細分市場、績效及預測，2019-2024 年、2024-2029 年、2034 年
銅-67用於標靶放射線治療
銅-67 臨床試驗
全球放射熱成像市場、放射性同位素銅 (Cu) 64 個細分市場、績效及預測，2019-2024 年、2024-2029 年、2034 年
用於 PET 成像的銅-64
銅-64用於放射治療
全球放射性熱療市場、其他放射性同位素細分市場、按放射性同位素、實際和預測，2019-2024 年、2024-2029 年、2034 年
鐳-223、釤-153
治療診斷學中的其他新興放射性同位素

第7章區域和國家分析

全球放射熱療市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球放射熱療市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第 17 章德國市場

第 18 章法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第 25 章：加拿大市場

第26章南美洲市場

第 27 章：巴西市場

第28章中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

放射治療市場：競爭格局
放射治療市場：公司簡介
- Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Siemens Healthineers
Orano Med
Curium SAS
IBA Molecular
The Eckert & Ziegler Group
Advanced Accelerator Applications（AAA）
Telix Pharmaceuticals Limited.
Abdera Therapeutics
Blue Earth Diagnostics
Sirtex Medical Limited
Y-mAbs Therapeutics Inc.
ITM Radiopharma
NorthStar Medical Radioisotopes LLC
Trasis SA
Molecular Targeting Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第 34 章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029 年放射治療市場：提供新機會的國家
2029 年放射治療市場：細分市場將帶來新機會
放射治療市場 2029：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第 36 章附錄

簡介目錄

Product Code: r25249

Radiotheranostics refers to a medical approach that combines diagnoses and treatments using imaging methods with radioactive substances to precisely identify specific targets within the body. This method is employed for delivering targeted radiation therapy to defined locations, enabling precise and tailored cancer treatment while minimizing damage to healthy tissues. This approach enhances treatment outcomes and improves patient care.

The primary radiotheranostics radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that occurs naturally at extremely low levels in the earth's crust but is predominantly man-made. It is used for skeletal and heart muscle scans and imaging of various organs such as the brain, thyroid, lungs, liver, spleen, kidneys, gall bladder, bone marrow, salivary and lacrimal glands, as well as in some specialized medical research. The different approaches include targeted therapeutic and targeted diagnostic applications in both oncology and non-oncology. The end users of this technology include hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.94 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

The rising incidence of cancer is anticipated to drive the growth of the radiotheranostics market in the future. Cancer is characterized by the uncontrolled development of certain cells in the body that spread to other areas. Radiotheranostics medications are widely used in oncology to provide the concept of personalized medicine through paired diagnostic and therapeutic radionuclide probes. These probes enable selective and targeted detection and treatment of specific (typically cancerous) cells, tailored to the patient's specific condition to enhance treatment efficacy and improve clinical outcomes. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is propelling the radiotheranostics market.

The increasing adoption of personalized medicine is poised to contribute to the growth of the radiotheranostics market. Personalized medicine, an innovative healthcare approach tailoring medical treatments to individual patient characteristics, is facilitated by radiotheranostics. This approach, utilizing specific radiopharmaceuticals, enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on the patient's unique characteristics. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. The increasing adoption of personalized medicine is a key driver for the growth of the radiotheranostics market.

An emerging trend in the radiotheranostics market is the focus on product innovations. Major companies are directing their efforts towards creating innovative products to solidify their market positions. For instance, Advanced Cyclotron Systems Inc., a Canada-based company specializing in cyclotrons for medical isotope production, introduced TR-ALPHA in May 2023. This innovation is designed for the production of alpha-emitting radioisotopes used in cancer treatment. TR-ALPHA addresses market demands for a low-cost cyclotron capable of producing substantial amounts of Astatine-211, a promising alpha-emitting radioisotope. This product is smaller, more cost-effective, and easier to operate compared to previous cyclotron models, making it an ideal solution for efficiently producing therapeutic alpha-emitting radioisotopes.

Major companies in the radiotheranostics market are forming strategic partnerships to develop new products and strengthen their market positions. Collaborations and partnerships in this market facilitate the pooling of resources, expertise, and research efforts, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. In April 2022, Ion Beam Applications partnered with SCK CEN to advance the production of the radioisotope Actinium-225, a crucial element in cancer treatment. This collaboration aims to establish a state-of-the-art production facility in Mol, Belgium, combining expertise in particle accelerators and the provision of rare raw materials. Such collaborations are crucial for making radiotheranostic solutions commercially viable for treating various cancers with enhanced precision.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. This strategic acquisition is intended to broaden Ariceum's portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and expand its operations in the US. Theragnostics Ltd., a US-based radiopharmaceutical company, specializes in offering radio-theranostic solutions.

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotheranostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotheranostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
2) By Approach: Targeted Therapeutic; Targeted Diagnostic
3) By Application: Oncology; Non-Oncology
4) By End-Users: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Technetium-99: Technetium-99m; Technetium-99 Pertechnetate
2) By Gallium-68: Gallium-68 DOTATATE; Gallium-68 PSMA
3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment; Iodine-131 For Hyperthyroidism Treatment
4) By Iodine-123: Iodine-123 For Thyroid Scans; Iodine-123 For Cardiac Imaging
5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging; FDG For Brain Imaging
6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer; Yttrium-90 For Radioimmunotherapy
7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer; Lutetium-177 DOTATATE For Neuroendocrine Tumors
8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy; Copper-67 In Clinical Trials
9) By Copper (Cu) 64: Copper-64 For PET Imaging; Copper-64 For Radiotherapy
10) By Other Radioisotopes: Radium-223; Samarium-153; Other Emerging Radioisotopes In Theranostics
Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Radiotheranostics Growth Analysis And Strategic Analysis Framework

5.1. Global Radiotheranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Radiotheranostics Market Growth Rate Analysis
5.4. Global Radiotheranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Radiotheranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Radiotheranostics Total Addressable Market (TAM)

6. Radiotheranostics Market Segmentation

6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Technetium-99
Gallium-68
Iodine-131
Iodine-123
Fludeoxyglucose-18F
Yttrium-90
Lutetium (Lu) 177
Copper (Cu) 67
Copper (Cu) 64
Other Radioisotopes
6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapeutic
Targeted Diagnostic
6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Non-Oncology
6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pharmaceutical And Biotechnology Companies
Other End-Users
6.5. Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Technetium-99m
Technetium-99 Pertechnetate
6.6. Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gallium-68 DOTATATE
Gallium-68 PSMA
6.7. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iodine-131 For Thyroid Cancer Treatment
Iodine-131 For Hyperthyroidism Treatment
6.8. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iodine-123 For Thyroid Scans
Iodine-123 For Cardiac Imaging
6.9. Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
FDG For Oncology Imaging
FDG For Brain Imaging
6.10. Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Yttrium-90 Microspheres For Liver Cancer
Yttrium-90 For Radioimmunotherapy
6.11. Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lutetium-177 PSMA For Prostate Cancer
Lutetium-177 DOTATATE For Neuroendocrine Tumors
6.12. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Copper-67 For Targeted Radiotherapy
Copper-67 In Clinical Trials
6.13. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Copper-64 For PET Imaging
Copper-64 For Radiotherapy
6.14. Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radium-223; Samarium-153
Other Emerging Radioisotopes In Theranostics

7. Radiotheranostics Market Regional And Country Analysis

7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotheranostics Market

8.1. Asia-Pacific Radiotheranostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotheranostics Market

9.1. China Radiotheranostics Market Overview
9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotheranostics Market

10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotheranostics Market

11.1. Japan Radiotheranostics Market Overview
11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotheranostics Market

12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotheranostics Market

13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotheranostics Market

14.1. South Korea Radiotheranostics Market Overview
14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotheranostics Market

15.1. Western Europe Radiotheranostics Market Overview
15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotheranostics Market

16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotheranostics Market

17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotheranostics Market

18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotheranostics Market

19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotheranostics Market

20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotheranostics Market

21.1. Eastern Europe Radiotheranostics Market Overview
21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotheranostics Market

22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotheranostics Market

23.1. North America Radiotheranostics Market Overview
23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotheranostics Market

24.1. USA Radiotheranostics Market Overview
24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotheranostics Market

25.1. Canada Radiotheranostics Market Overview
25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotheranostics Market

26.1. South America Radiotheranostics Market Overview
26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotheranostics Market

27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotheranostics Market

28.1. Middle East Radiotheranostics Market Overview
28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotheranostics Market

29.1. Africa Radiotheranostics Market Overview
29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

30.1. Radiotheranostics Market Competitive Landscape
30.2. Radiotheranostics Market Company Profiles
- 30.2.1. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Radiotheranostics Market Other Major And Innovative Companies

31.1. Siemens Healthineers
31.2. Orano Med
31.3. Curium SAS
31.4. IBA Molecular
31.5. The Eckert & Ziegler Group
31.6. Advanced Accelerator Applications (AAA)
31.7. Telix Pharmaceuticals Limited.
31.8. Abdera Therapeutics
31.9. Blue Earth Diagnostics
31.10. Sirtex Medical Limited
31.11. Y-mAbs Therapeutics Inc.
31.12. ITM Radiopharma
31.13. NorthStar Medical Radioisotopes LLC
31.14. Trasis S.A.
31.15. Molecular Targeting Technologies Inc.

32. Global Radiotheranostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotheranostics Market

34. Recent Developments In The Radiotheranostics Market

35. Radiotheranostics Market High Potential Countries, Segments and Strategies

35.1 Radiotheranostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Radiotheranostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Radiotheranostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies